Who may participate

This study is seeking male participants.
You may not take part in this study if:


•You are younger than 18 years or older than 65 years, you weigh less than or equal to 50 kg (45 kg for Japanese participants) or you are outside of the limits for Body Mass Index (16 – 32 kg/m2)
• You are regularly taking prescription and non-prescription medications or supplements, or you are suffering from a chronic illness.
• You smoke more than 5 cigarettes a day or consume an equivalent quantity of tobacco / nicotine-containing products.


There are other requirements for participation in this study. Please read attentively the Informed Consent Document (ICD), more explanation will be provided by the study staff during the screening process

See calendar

Condition

Healthy

Age

18-65

Sex

Male

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in Brussels, Belgium.

 

Part D:
The study part will last for about 9 weeks and consists of
• A screening examination.
• You will stay in the PCRU for 1 treatment period for a total stay of 13 days and 12 nights in the PCRU.
• The follow up phone call will take place approximately 28–35 days after the last dosing.

You will be screened within 28 days prior to the first dose of study intervention.
Throughout the study, staff will closely monitor your health status and collect data.
You will not personally derive any benefit from your participation in this study, but the results obtained could be very important for the development of medicines and treatments which will benefit other people.

How long is the study?

Part D: 9 weeks

Compensation

For the entire study (Part D): € 3.600